HGH Fragment 176-191

Composition

Each pack contains:

• One vial with HGH Fragment 176–191 – 5 mg
• One ampoule with 2 ml sterile water for injection

Pharmacological Effects

• Lipolytic (fat-burning): Mimics the C-terminal region of GH (amino acids 176–191), selectively targeting fat metabolism without growth effects.
• Mechanism of Action:
  • Increases lipolysis via hormone-sensitive lipase (HSL) activation.
  • Inhibits lipogenesis by blocking insulin-mediated fat storage.
  • Does not bind GH receptors → no muscle growth or blood sugar disruption.

Indications

• Obesity and metabolic syndrome (preclinical evidence).
• Localized fat reduction (e.g., abdominal adiposity).
• Type 2 diabetes adjunct (improves insulin sensitivity in animal studies).

Recommended Dose

• Research dose: 250–500 mcg/day (subcutaneous), divided into 1–2 doses.
• Cycle length: Typically 4–12 weeks (fat loss peaks around week 8).
• Best timing: Morning and/or pre-workout; fasted state enhances lipolysis.
• Reconstitution: Use bacteriostatic water (stable for 14+ days refrigerated).

Side Effects

• Minimal systemic effects (no GH or IGF-1 receptor activity).
• Possible mild reactions:
  • Injection site redness or itching.
  • Transient hunger (rare, unlike GHRP-6).
  • Mild water retention (higher doses).

Contraindication

• Pregnancy or lactation (no safety data).
• Active cancer (theoretical metabolic interaction risk).
• Hypersensitivity to peptide components.

Storage Conditions

• Unreconstituted vials: Store at 2–8°C (refrigerated); protect from light.
• Reconstituted solution: Stable for 14–30 days at 2–8°C (with bacteriostatic water).
• Avoid freezing and excessive agitation.

Disclaimer: This product is not for human use. It is intended for laboratory research only. Not for diagnostic, therapeutic, or veterinary purposes. Buyer assumes all responsibility for proper handling and legal compliance. Keep out of reach of children. Not for consumption.